Women affected by premenstrual syndrome (PMS) appear to experience less intense and debilitating symptoms after taking ...

The primary value of placebo controls in clinical trials is the minimization of bias.

For patients with resected stage IB-IIIA epidermal growth factor receptor-mutated non-small cell lung cancer, molecular ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy and as the backbone for novel ...

Pooled data analysis shows that pain relief is only marginally better than placebo. A pooled analysis of existing research, ...

Patients with diabetes or obesity receiving GLP-1 RAs are unlikely to experience an increase in the already low rates of ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Topline data were announced from a phase 3 trial evaluating solriamfetol in adults with attention deficit hyperactivity disorder (ADHD).

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...